Disparity in clinical outcomes between pure and combined pulmonary large-cell neuroendocrine carcinoma: A multi-center retrospective study-Reference-Cited by-同舟云学术

Disparity in clinical outcomes between pure and combined pulmonary large-cell neuroendocrine carcinoma: A multi-center retrospective study

Published:2020-01 Issue: Volume:139 Page:118-123
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Zhang Jia-Tao,Li Ye,Yan Li-Xu,Zhu Zheng-Fei^ORCID,Dong Xiao-Rong,Chu Qian,Wu Lin,Zhang Hong-Mei,Xu Chun-Wei,Lin Gen^ORCID,Yu Zong-Yang,Hu Jie,Zhu Bo,Wang Hui-Juan,Yang Fan,Song Zheng-Bo,Han Zheng-Bo,Li Meng-Xia,Lin Jie,Wu Yi-Long^ORCID,Wang Jin-Liang,Zhong Wen-Zhao^ORCID

Funder

National Natural Science Foundation of China

Chinese Society of Clinical Oncology project

Guangdong Provincial People's Hospital Young Talent Project

High-level Hospital Construction Project

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference20 articles.

1. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases;Travis;Am. J. Surg. Pathol.,1991

2. The 2015 World Health Organization classification of lung tumors: new entities since the 2004 classification;Mengoli;Pathologica,2018